Concepedia

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Kenneth H. Mayer, Jean‐Michel Molina, Melanie Thompson, Peter L. Anderson, Karam Mounzer, Joss J De Wet, Edwin DeJesus, Heiko Jessen, Robert M. Grant, Peter Ruane,

The Lancet · 2020 · 424 citations · 49 references

DOIFull text

Open access

Concepts

References

49

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study

Ömer Toprak, Hüseyin Kurt, Yasin Sarı et al. · Kidney & Blood Pressure Research · 2017 · 29.7K citations · Full text

, , +17

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

Andrew S. Levey, Josef Coresh, Kline Bolton et al. · Data Archiving and Networked Services (DANS) · 2002 · 11.7K citations

, , +13

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

Robert M. Grant, Javier R. Lama, Peter L. Anderson et al. · New England Journal of Medicine · 2010 · 5.1K citations · Full text

, , +14

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

David C. Goff, Donald M. Lloyd‐Jones, Glen C. Bennett et al. · Journal of the American College of Cardiology · 2013 · 5K citations · Full text

, , +14

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

David C. Goff, Donald M. Lloyd‐Jones, Glen C. Bennett et al. · Circulation · 2013 · 3.7K citations · Full text

, , +14